Editorial. A neurosurgery resident’s response to COVID-19: anything but routine

Autor Choi, Bryan D.
Vydáno v J Neurosurg (2020)

IDH mutational status and the immune system in gliomas: a tale of two tumors?

Autor Choi, Bryan D., Curry, William T.
Vydáno v Transl Cancer Res (2017)

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas

Autor Richardson, Leland G., Choi, Bryan D., Curry, William T.
Vydáno v Transl Cancer Res (2019)

Regulatory T cells move in when gliomas say “I-DO”

Autor Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Vydáno 2012

Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma

Autor Choi, Bryan D., O’Rourke, Donald M., Maus, Marcela V.
Vydáno v J Target Ther Cancer (2017)

A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system

Autor Choi, Bryan D., Pastan, Ira, Bigner, Darell D., Sampson, John H.
Vydáno 2013

Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic

Autor Gedeon, Patrick C., Choi, Bryan D., Sampson, John H., Bigner, Darell D.
Vydáno v Drugs Future (2013)

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies

Autor Choi, Bryan D., Maus, Marcela V., June, Carl H., Sampson, John H.
Vydáno v Clin Cancer Res (2018)

Isocitrate dehydrogenase 1 (IDH1): what it means to the neurosurgeon

Autor Hodges, Tiffany R., Choi, Bryan D., Bigner, Darell D., Yan, Hai, Sampson, John H.
Vydáno 2013

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody

Autor Choi, Bryan D, Gedeon, Patrick C, Sanchez-Perez, Luis, Bigner, Darell D, Sampson, John H
Vydáno 2013

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy

Autor Sanchez-Perez, Luis, Suryadevara, Carter M, Choi, Bryan D, Reap, Elizabeth A, Sampson, John H
Vydáno v Oncoimmunology (2014)

Enzyme Redesign Guided by Cancer-Derived IDH1 Mutations

Autor Reitman, Zachary J., Choi, Bryan D., Spasojevic, Ivan, Bigner, Darell D., Sampson, John H., Yan, Hai
Vydáno 2012

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

Autor Choi, Bryan D., Suryadevara, Carter M., Gedeon, Patrick C., Herndon, James E., Sanchez-Perez, Luis, Sampson, John H.
Vydáno 2013

An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma

Autor Gedeon, Patrick C, Choi, Bryan D, Hodges, Tiffany R, Mitchell, Duane A, Bigner, Darell D, Sampson, John H
Vydáno 2013

Sporadic NF2 Mosaic: Multiple spinal schwannomas presenting with severe, intractable pain following pregnancy

Autor Zimering, Jeffrey H., Choi, Bryan D., Koch, Matthew J., Dewitt, John C., Stemmer-Rachamimov, Anat, Shin, John H.
Vydáno v Interdiscip Neurosurg (2017)

Immunotherapy for malignant glioma

Autor Suryadevara, Carter M., Verla, Terence, Sanchez-Perez, Luis, Reap, Elizabeth A., Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Vydáno v Surg Neurol Int (2015)

Imaging of Convection Enhanced Delivery of Toxins in Humans

Autor Mehta, Ankit I., Choi, Bryan D., Raghavan, Raghu, Brady, Martin, Friedman, Allan H., Bigner, Darell D., Pastan, Ira, Sampson, John H.
Vydáno 2011

Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis

Autor Choi, Bryan D., Gedeon, Patrick C., Kuan, Chien-Tsun, Sanchez-Perez, Luis, Archer, Gary E., Bigner, Darell D., Sampson, John H.
Vydáno 2013

EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma

Autor Choi, Bryan D., Archer, Gary E., Mitchell, Duane A., Heimberger, Amy B., McLendon, Roger E., Bigner, Darell D., Sampson, John H.
Vydáno 2009

Are BiTEs the “missing link” in cancer therapy?

Autor Suryadevara, Carter M, Gedeon, Patrick C, Sanchez-Perez, Luis, Verla, Terence, Alvarez-Breckenridge, Christopher, Choi, Bryan D, Fecci, Peter E, Sampson, John H
Vydáno v Oncoimmunology (2015)